Keyphrases
Prospective Observational Study
100%
Continuous Dose
100%
Target Attainment
100%
Piperacillin
100%
Critical Illness
100%
Piperacillin-tazobactam
100%
Critically Ill Patients
40%
Combined Target
40%
Treatment Course
40%
Netherlands
20%
University Medical Centre
20%
Patient Demographics
20%
Adult Patients
20%
Intensive Care Unit
20%
Therapeutic Drug Monitoring
20%
Drug Concentration
20%
Intermittent Dosing
20%
Pharmacodynamics
20%
Pharmacokinetic Profile
20%
Patient Cohort
20%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Cumulative Dose
20%
β-lactam Antibiotics
20%
Pharmacokinetics
20%
Optimal Dosing
20%
Dosing Schedule
20%
Attractive Alternatives
20%
Pharmacology, Toxicology and Pharmaceutical Science
Observational Study
100%
Critical Illness
100%
Piperacillin Plus Tazobactam
100%
Piperacillin
100%
Pharmacokinetics
40%
Drug Concentration
20%
Pharmacodynamics
20%
Beta Lactam Antibiotic
20%
Therapeutic Drug Monitoring
20%